Background
Up to 25% of severely injured patients develop trauma-induced coagulopathy. To study interventions for this vulnerable population for whom consent cannot be obtained easily, the Food and Drug Administration (FDA) issued regulations for emergency research with an exception from informed consent (ER-EIC). We describe the community consultation and public disclosure (CCPD) process in preparation an ER-EIC study namely the Control of Major Bleeding after Trauma (COMBAT) study.
Methods
The CCPD was guided by the four bioethical principles. We employed a multimedia approach including one-way communications (newspaper ads, brochures, television, radio, and web) and two-way communications (interactive in-person presentations at community meetings, printed and online feedback forms) to reach the trials catchment area (Denver County’s population: 643,000 and the Denver larger metro area where commuters reside: 2.9 million). Particular attention was given to special-interests groups (e.g., Jehovah Witnesses, homeless) and to Spanish-speaking communities (brochures and presentations in Spanish). Opt-out materials were available during on-site presentations or via the COMBAT website.
Results
227 community organizations were contacted. Brochures were distributed to 11 medical clinics and 3 homeless shelters. The multimedia campaign had the potential to reach an estimated audience of 1.5 million individuals in large metro Denver area, the majority via one-way communication and 1900 in two-way communications. This resource intensive process cost over $84,000.
Conclusions
The CCPC process is resource-intensive, costly, and complex. While the multimedia CCPC reached a large audience, the effectiveness of this process remains elusive. The templates can be helpful to similar ER-EIC studies.